Exogenous Treatment of Caffeic Acid and Methylglyoxal Synergistically Enhances Anticancer Effect in Prostate Cancer via Inhibition of Glyoxalase‐1
The Prostate · 2025
DOI: 10.1002/pros.24849 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prostate, 2025. Verfasst von Km Anjaly und 1 weiteren Autor:innen. Beteiligte Einrichtung: Radiation and Cancer Therapeutics Lab, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India. Hauptthemen laut MEDLINE: Lactoylglutathione Lyase, Prostatic Neoplasms, Pyruvaldehyde, Caffeic Acids. Die Arbeit nennt 21 Literaturangaben. Gefördert von: The study was supported by the Jawaharlal Nehru University (UGC-SAP F.3-12/2016/DRS-I); Department of Science and Technology, Ministry of Science and Technolog….
Abstract (Originalsprache)
Background
Caffeic acid (CA), a dietary compound, has been studied for its potential impact on inhibiting prostate cancer (PCa) growth. PCa is often associated with heightened expression of glyoxalase‐1 (Glo‐1), making it a target for potential therapeutic interventions. CA's mechanisms in suppressing Glo‐1 expression and its effects on PCa cell proliferation are areas of interest for understanding its potential as an anticancer agent.
Methods
Cellular viability and proliferation were evaluated through MTT and clonogenic assays. The expression levels of particular proteins were assessed using western blot analysis and immunocytochemistry.
Results
Results indicated significant reduction in PCa cell proliferation by CA, accompanied by induction of DNA double‐strand breaks, leading to apoptotic cell death through decreased pro‐caspases expression. Additionally, CA was found to inhibit Glo‐1 expression. To enhance CA's anticancer effect, a novel approach was taken by combining it with methylglyoxal (MG). Exogenous MG treatment, a glycolysis by‐product and glyoxalase enzyme substrate, exhibited dose and time‐dependent toxicity in PCa cells when combined with CA. This combination treatment showed heightened toxicity against PCa cells, attributed to CA's inhibition of Glo‐1 expression and the nontoxic doses of exogenous MG. Consequently, increased levels of endogenous MG were observed, leading to apoptosis and suggesting a promising strategy for targeting glyoxalase oncogenic signaling pathways in PCa with minimal adverse effects.
Conclusion
The study highlights the potential of CA as a therapeutic agent for inhibiting PCa growth through multiple mechanisms, including the induction of apoptotic cell death and inhibition of Glo‐1 expression. Combining CA with MG enhances its anticancer effects, offering a promising strategy for targeting glyoxalase oncogenic pathways in PCa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Radiation and Cancer Therapeutics Lab, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India.
ORCID-Profile: Ashu Bhan Tiku
Förderung
- The study was supported by the Jawaharlal Nehru University (UGC-SAP F.3-12/2016/DRS-I); Department of Science and Technology, Ministry of Science and Technolog…
Zitieren
APA
Anjaly, K., & Tiku, A. B. (2025). Exogenous Treatment of Caffeic Acid and Methylglyoxal Synergistically Enhances Anticancer Effect in Prostate Cancer via Inhibition of Glyoxalase‐1. The Prostate. https://doi.org/10.1002/pros.24849
Vancouver
Anjaly K, Tiku AB. Exogenous Treatment of Caffeic Acid and Methylglyoxal Synergistically Enhances Anticancer Effect in Prostate Cancer via Inhibition of Glyoxalase‐1. The Prostate. 2025. doi:10.1002/pros.24849
BibTeX
@article{Anjaly2025,
author = {Anjaly, Km and Tiku, Ashu Bhan},
title = {Exogenous Treatment of Caffeic Acid and Methylglyoxal Synergistically Enhances Anticancer Effect in Prostate Cancer via Inhibition of Glyoxalase‐1},
journal = {The Prostate},
year = {2025},
doi = {10.1002/pros.24849}
}
EUVIMED